Health Care & Life Sciences » Biotechnology | Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,934.80
37,879.40
21,882.50
53,171.30
217,339.20
171,894.10
Total Accounts Receivable
112.60
106.60
65.30
115.30
136.60
296.40
Other Current Assets
179.60
874.50
1,019.60
2,257.00
2,106.20
9,253.30
Total Current Assets
2,227.00
38,860.40
22,967.40
55,543.60
219,582.00
181,443.80
Net Property, Plant & Equipment
39.30
60.20
50.00
38.90
38.80
56
Intangible Assets
22,187.10
21,414.90
23,610.50
20,853.30
17,686.60
17,230.90
Other Assets
161.50
331.30
-
-
561.30
489
Total Assets
24,614.90
60,666.80
46,627.90
76,435.80
237,868.80
199,219.70
ST Debt & Current Portion LT Debt
1,400.40
-
-
-
-
Accounts Payable
1,174.10
1,612.30
2,887.90
3,839.40
4,727.40
Other Current Liabilities
3,853.70
1,672.50
2,136.40
6,795.10
5,484.20
Total Current Liabilities
6,428.10
3,284.80
5,024.40
10,634.50
10,211.50
Provision for Risks & Charges
-
134.40
-
-
-
Other Liabilities
4,041.80
5,003.60
13,872.90
17,590.60
19,989.60
Total Liabilities
10,469.90
8,422.80
18,897.30
28,225.10
30,201.10
Common Equity (Total)
14,145.10
52,244.00
27,730.60
48,210.70
207,667.70
Total Shareholders' Equity
14,145.10
52,244.00
27,730.60
48,210.70
207,667.70
Total Equity
14,145.10
52,244.00
27,730.60
48,210.70
207,667.70
Liabilities & Shareholders' Equity
24,614.90
60,666.80
46,627.90
76,435.80
237,868.80

About Aurinia Pharmaceuticals

View Profile
Address
4464 Markham Street
Victoria British Columbia V8Z 7X8
Canada
Employees -
Website http://www.auriniapharma.com
Updated 07/08/2019
Aurinia Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases particularly lupus nephritis. The company was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada. .